La. Speicher et al., INTERACTION OF AN ESTRAMUSTINE PHOTOAFFINITY ANALOG WITH CYTOSKELETALPROTEINS IN PROSTATE CARCINOMA-CELLS, Molecular pharmacology, 46(5), 1994, pp. 866-872
To identify specific drug targets of the antimitotic drug estramustine
, a photoaffinity analogue, arbamyl]estradiol-3-N-bis(2-chloroethyl)ca
rbamate, was synthesized and reacted in competition assays with cytosk
eletal protein preparations. By attaching the photoaffinity ligand to
the 17 beta-position of the steroid D-ring, the cytotoxic properties o
f the drug were maintained. In cytoskeletal protein preparations from
human prostate carcinoma cells (DU 145) or a clonally selected, estram
ustine-resistant cell line (E4), the major microtubule-associated prot
ein (MAP) present was MAP4. In both cytoskeletal fractions and reconst
ituted microtubules, carbamyl]estradiol-3-N-bis(2-chloroethyl)carbamat
e bound to both MAP4 and tubulin. From competition assays, the apparen
t binding constant for MAP4 from DU 145 cells was 15 mu M. Similar cal
culations for tubulin gave values of 13 mu M (bovine brain), 19 mu M (
DU 145 wild-type cells), and 25 mu M (E4 cells). The identification of
these cytoskeletal proteins as specific drug targets provides a direc
t explanation for the antimicrotubule and antimitotic effects of estra
mustine.